Trial Design Webinars

  1. Supplies Pain Points — Slow Enrollment 10/27/2025

    Without real-time visibility into enrollment rates, site performance, and supply levels, it becomes nearly impossible to proactively manage risk and optimize your trials.

  2. Fixing The Friction In Trial Enrollment: From Persuasion To Activation 10/20/2025

    Drawing on evidence from real-world trials, this session will offer a practical roadmap for transforming a patient’s “no” into an informed and empowered “yes.” It’s not about persuading harder; it’s about designing smarter.

  3. No Statistically Significant Progress — Yet 10/20/2025

    Dr. Jennifer E. Miller of the Yale School of Medicine says her Good Pharma Scorecard found no statistically significant diversity improvements in oncology trials over the past decade, despite decades of policy efforts and major investments.

  4. Community Trust Can't Be Outsourced 10/20/2025

    Dr. Brescher underscores that authentic community trust can’t come from corporate messaging alone. It grows when people from within the community lead research conversations and build relationships grounded in shared experience.

  5. From Outreach To Engagement: Building Trust That Lasts 10/20/2025

    In this clip, Camille Campbell emphasizes that meaningful inclusion requires sustained engagement. Lasting trust develops through repeated presence and genuine collaboration between research teams and the communities they hope to serve.

  6. What Bright Spots In Trial Diversity Are Doing Differently 10/20/2025

    According to Dr. Miller, the “bright spot” sponsors making real progress are those abandoning one-size-fits-all vendors, investing in patient navigators, and leveraging broader site networks to improve representation across studies.

  7. The Real Story Behind SOGI Data In Clinical Trials 10/20/2025

    In this clip, Dr. Jessica Brecher of Tectonic Therapeutic reveals why many trial sites refuse to activate sexual-orientation and gender-identity (SOGI) questions — from investigator discomfort to patient fears — and why collecting these data is scientifically essential.

  8. Health Equity Isn't A Buzzword — It's A Business Imperative 10/20/2025

    Dr. Camille (Pope) Campbell of Biogen explains that health equity isn’t just moral — it’s strategic. She details how Biogen integrates equity into community outreach, operations, and commercialization to improve both outcomes and business impact.

  9. The End Of Clinical Trial-And-Error: AI-Powered Design For Protocol Certainty 10/2/2025

    Discover how AI-powered predictive analytics and protocol optimization tools can improve trial feasibility, forecast patient enrollment, and reduce burden.

  10. ADCs In Oncology Trials Webinar 10/2/2025

    Whether you are preparing to launch your first ADC study or looking to optimize current programs, this session will deliver practical insights you can put into action immediately.